Brazilian president Luiz Inácio Lula da Silva signed a decree last week (4 May) issuing compulsory licensing for the HIV/AIDS drug efavirenz, made by pharmaceutical company Merck...The announcement comes after the health ministry rejected Merck's offer on Thursday (3 May) to drop the price per pill by 30 per cent, reasoning that it is still higher than the price being offered to Thailand.